CEMIPLIMAB for Squamous cell carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 80 adverse event reports in the FDA FAERS database where CEMIPLIMAB was used for Squamous cell carcinoma.
Most Reported Side Effects for CEMIPLIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 68 | 6.7% | 8 | 34 |
| Pyrexia | 49 | 4.8% | 9 | 41 |
| Pneumonia | 41 | 4.0% | 3 | 34 |
| Dyspnoea | 40 | 3.9% | 7 | 28 |
| Pneumonitis | 38 | 3.7% | 15 | 25 |
| Off label use | 35 | 3.4% | 11 | 19 |
| Diarrhoea | 34 | 3.3% | 3 | 12 |
| Rash | 34 | 3.3% | 1 | 13 |
| Cytokine release syndrome | 33 | 3.2% | 5 | 30 |
| Pain | 33 | 3.2% | 4 | 16 |
| Asthenia | 32 | 3.1% | 5 | 21 |
| Nausea | 31 | 3.0% | 1 | 12 |
| Anaemia | 30 | 2.9% | 9 | 27 |
| Disease progression | 30 | 2.9% | 11 | 11 |
| Drug ineffective | 30 | 2.9% | 8 | 15 |
Other Indications for CEMIPLIMAB
Squamous cell carcinoma of skin (245)
Product used for unknown indication (62)
Non-small cell lung cancer (51)
Neoplasm malignant (47)
Non-small cell lung cancer stage iv (41)
Basal cell carcinoma (38)
Lung adenocarcinoma stage iv (37)
Malignant melanoma (34)
Metastatic squamous cell carcinoma (34)
Cervix carcinoma (27)
Other Drugs Used for Squamous cell carcinoma
CARBOPLATIN (608)
CISPLATIN (522)
PACLITAXEL (496)
PEMBROLIZUMAB (470)
FLUOROURACIL (430)
NIVOLUMAB (343)
CETUXIMAB (283)
CEMIPLIMAB-RWLC (234)
DOCETAXEL (198)
GEMCITABINE (109)